MiR-99a targets CTDSPL and TRIB2, and regulates their expressions in most childhood AML and CML, which may reveal a new post-transcriptional mechanism of regulation in the myeloid lineage. Here, TRIB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.